MIRIAM GALAN-DEJESUS: Open Payments
NPI 1245380518 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,826 in 87 payments from 20 companies in 2025. Trend: 2023 $1,659 · 2024 $1,503 · 2025 $1,826
Food & beverage: $1,826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $462 |
| PFIZER INC. | 19 | $355 |
| Novo Nordisk Inc | 12 | $210 |
| AstraZeneca Pharmaceuticals LP | 3 | $184 |
| Abbott Laboratories | 7 | $156 |
| Astellas Pharma US Inc | 5 | $95 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Lilly USA, LLC | 2 | $43 |
| Eisai Inc. | 1 | $33 |
| Medtronic, Inc. | 1 | $31 |
Products named: NURTEC ODT, VRAYLAR, AIRSUPRA, UBRELVY, FREESTYLE LIBRE 3, Veozah, ELIQUIS, Ozempic.
Industry payments across VA — which companies pay providers there.
